论文部分内容阅读
3α-bromo-epipicropodophyllin was prepared and its inhibition activities against KB cells andL1210 leukemia cells in vitro are higher than those of VP-16, a widely used drug in clinic at present. This is the firsttime to introduce substitution at C-3 of ri